# Prospective Trial to Evaluate the Safety and Efficacy to Treat Esophageal Cancer Using 5-FU, Oxaliplatin, and Docetaxel

> **NCT04699994** · PHASE2 · UNKNOWN · sponsor: **Keio University** · enrollment: 60 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma

## Interventions

- **DRUG:** FLOT therapy

## Key facts

- **NCT ID:** NCT04699994
- **Lead sponsor:** Keio University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-25
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04699994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04699994, "Prospective Trial to Evaluate the Safety and Efficacy to Treat Esophageal Cancer Using 5-FU, Oxaliplatin, and Docetaxel". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04699994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*